APPOINTMENTS: Apellis, Araim, Ascendis, Chronos, Intrexon and Proteostasis
Chrono Therapeutics Inc. has hired two ex-Shire PLC executives to lead clinical development for the recently acquired pipeline programs it picked up from the Irish pharma company. Meanwhile, Apellis Pharmaceuticals Inc., Ascendis Pharma A/S, Intrexon Corporation and Proteostasis Therapeutics Inc. have made senior appointments and Araim Pharmaceuticals has named a new chair for its board of directors.
You may also be interested in...
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
US FDA will hold 10 December advisory committee on Pfizer/BioNTech's just-filed application; the WHO issued a recommendation against Gilead's Veklury for hospitalized patients.
Board directors appointed at Athersys, Trillium Therapeutics and Viatris